AbCellera Biologics Inc.ABCLNASDAQ
Loading
Year-over-year free cash flow growth rate
| Period | Value |
|---|---|
| Q4 2025 | 27.53% |
| Q3 2025 | -34.42% |
| Q2 2025 | -106.26% |
| Q1 2025 | 6.09% |
| Q4 2024 | 50.34% |
| Q3 2024 | 3.40% |
| Q2 2024 | 25.20% |
| Q1 2024 | -93.43% |
| Q4 2023 | -66.57% |
| Q3 2023 | -171.32% |
| Q2 2023 | 87.24% |
| Q1 2023 | -417.76% |
| Q4 2022 | 113.34% |
| Q3 2022 | -157.95% |
| Q2 2022 | 180.40% |
| Q1 2022 | 427.92% |
| Q4 2021 | -80.22% |
| Q3 2021 | -111.66% |
| Q2 2021 | 17.47% |
| Q1 2021 | 470562.02% |
| Q4 2020 | 99.71% |
| Q3 2020 | -134.51% |
| Q2 2020 | 450.94% |
| Q1 2020 | -5023.34% |
| Q4 2019 | 85.70% |
| Q3 2019 | -453.65% |
| Q2 2019 | 0.00% |
| Q1 2019 | 0.00% |